19 Organizations from the healthcare community unite to form COVID-19 testing industry consortium

Consortium members will work together to increase opportunities to accelerate research through enhanced collaboration and information sharing, with the ultimate goal of improving aspects of COVID-19 testing across the globe.

LabCorp and Infirmary Health form strategic partnership to provide Laboratory services across healthcare system

Multi-year deal will enhance lab services for patients and providers throughout eastern Gulf Coast region.

LabCorp to announce third quarter financial results on October 27, 2020

BURLINGTON, N.C. --(BUSINESS WIRE)--Sep. 28, 2020-- LabCorp (NYSE: LH) will release its third quarter of 2020 financial results before the market opens on Tuesday, Oct. 27, 2020 , and then will host a conference call and webcast beginning at 9:00 a.m. EDT to discuss the results.

LabCorp and GENFIT sign exclusive agreement to commercialize a novel diagnostic test for liver disease

LILLE, FRANCE; CAMBRIDGE, MA; & BURLINGTON, N.C.—Sep. 28, 2020— GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with metabolic and liver diseases, and LabCorp® (NYSE:LH), a leading global life sciences company that is focused on advancing health and guiding patient care decisions, have agreed to a five-year exclusive licensing agreement for GENFIT’s NIS4™ technology to help identify patients with at-risk non-alcoholic steatohepatitis (NASH).

New non-invasive test for lung cancer available exclusively from Labcorp

Blood-based test guides treatment decisions for patients with non-small cell lung cancer